These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 352712

  • 1. Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid.
    König W, Tesch H, Frickhofen N.
    Eur J Immunol; 1978 Jun; 8(6):434-7. PubMed ID: 352712
    [Abstract] [Full Text] [Related]

  • 2. Eosinophil chemotactic factor. Release from human polymorphonuclear neutrophils by arachidonic acid.
    Tesch H, König W, Frickhofen N.
    Int Arch Allergy Appl Immunol; 1979 Jun; 58(4):436-46. PubMed ID: 35469
    [Abstract] [Full Text] [Related]

  • 3. Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation.
    König W, Frickhofen N, Tesch H.
    Immunology; 1979 Apr; 36(4):733-42. PubMed ID: 437847
    [Abstract] [Full Text] [Related]

  • 4. Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes.
    Czarnetzki BM, König W, Lichtenstein LM.
    Int Arch Allergy Appl Immunol; 1978 Apr; 56(5):398-408. PubMed ID: 344231
    [Abstract] [Full Text] [Related]

  • 5. Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187.
    Czarnetzki BM, König W, Lichtenstein LM.
    J Immunol; 1976 Jul; 117(1):229-34. PubMed ID: 778263
    [Abstract] [Full Text] [Related]

  • 6. Subcellular localization of the eosinophil chemotactic factor (ECF) and its inactivator in human polymorphonuclear leucocytes (PMN).
    Frickhofen N, König W.
    Immunology; 1979 May; 37(1):111-22. PubMed ID: 468298
    [Abstract] [Full Text] [Related]

  • 7. Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis.
    König W, Czarnetzki BM, Lichtenstein LM.
    J Immunol; 1976 Jul; 117(1):235-41. PubMed ID: 932426
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Generation of leukotrienes and lipoxygenase factors from human polymorphonuclear granulocytes during bacterial phagocytosis and interaction with bacterial exotoxins.
    Bremm KD, Brom J, König W, Spur B, Crea A, Bhakdi S, Lutz F, Fehrenbach FJ.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):500-14. PubMed ID: 6326424
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
    Goetzl EJ, Goldman DW, Naccache PH, Sha'afi RI, Pickett WC.
    Adv Prostaglandin Thromboxane Leukot Res; 1982 Jul; 9():273-82. PubMed ID: 6283846
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Low molecular weight eosinophil chemotactic factor (ECF) production by rat peritoneal mononuclear phagocytes.
    Czarnetzki BM.
    Immunobiology; 1980 Apr; 157(1):62-6. PubMed ID: 6782008
    [Abstract] [Full Text] [Related]

  • 15. Chemotactic and chemokinetic stimulation of human eosinophil and neutrophil polymorphonuclear leukocytes by 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT).
    Goetzl EJ, Gorman RR.
    J Immunol; 1978 Feb; 120(2):526-31. PubMed ID: 621391
    [No Abstract] [Full Text] [Related]

  • 16. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity.
    Goetzl EJ, Wasserman SI, Austen F.
    Arch Pathol; 1975 Jan; 99(1):1-4. PubMed ID: 234219
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of polymorphonuclear-neutrophil derived eosinophil chemotactic factor by human serum.
    König W, Czarnetzki BM.
    Int Arch Allergy Appl Immunol; 1978 Jan; 57(5):399-410. PubMed ID: 352966
    [Abstract] [Full Text] [Related]

  • 18. Release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by calcium ionophore A23187 and phagocytosis.
    Gzarnetzki BM, Konig W, Lichtenstein LM.
    Nature; 1975 Dec 25; 258(5537):725-6. PubMed ID: 1107852
    [No Abstract] [Full Text] [Related]

  • 19. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid.
    Morita E, Schröder JM, Christophers E.
    J Immunol; 1990 Mar 01; 144(5):1893-900. PubMed ID: 2155268
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.